cp wire

CP Wire Articles

AmpliPhi Presents Case Study of Bacteriophage Used to Treat Drug Resistant Infection in Cystic Fibrosis Patient

AmpliPhi Biosciences Corporation (NYSE American: APHB) announced on 5/7/2018 a poster presentation of a successful case study of a patient with cystic fibrosis, suffering from recurrent multi-drug... read more

Thu, 06/7/18 - 09:20 am
Right-to-try and the Goldwater Institute’s views on the FDA

The right-to-try legislation guaranteeing that the FDA cannot deny patients the right to try experimental drugs was both championed and criticized by many groups. The conservative/... read more

Wed, 06/6/18 - 01:29 pm
Peloton Therapeutics Initiates Phase II Trials of Treatment for Rare Kidney Cancer

Peloton Therapeutics, Inc., announced on 6/6/2018 the dosing of the first patient in a Phase 2 trial evaluating the efficacy and safety of lead investigational oncology agent, PT2977, to treat von... read more

Wed, 06/6/18 - 09:33 am
Axovant Bets on Gene Therapy With $842 Million Deal With Oxford BioMedica
  • Axovant will license two products from Oxford BioMedica
  • The gene therapy based products have demonstrated long term improvement in motor function
  • Axovant shares are up 102%... read more
Wed, 06/6/18 - 09:17 am
BioCryst Urges Stockholders To Vote For Merger With Idera

BioCryst Pharmaceuticals, Inc. (NASDAQ:BCRX) (“BioCryst” or the “Company”), a pharmaceutical company focused on the development and commercialization of treatments for rare diseases, today issued... read more

Tue, 06/5/18 - 09:51 am

Pages